GlassScriptPhysician profile
Amanda D Rascon
NPI 1063157253
$2,074.08
in general payments reported to CMS, 2019-2025
20 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $383 · 2023: $910 · 2024: $348 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.21 | 2023-2025 | |
| Lilly USA, LLC | $309.50 | 2022-2024 | Jardiance, Trulicity, Mounjaro |
| Abbott Laboratories | $252.09 | 2022-2025 | Proclaim, Freestyle Libre 2, Octrode |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.95 | 2022-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $163.18 | 2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $153.63 | 2022-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $117.17 | 2025 | Caplyta |
| Lucid Diagnostics INC. | $95.11 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $75.58 | 2022-2023 | |
| Boston Scientific Corporation | $47.20 | 2023 | Watchman Access System |
| Novo Nordisk INC | $31.06 | 2023-2024 | Ozempic, Rybelsus |
| Dexcom, INC. | $28.43 | 2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $24.99 | 2022 | |
| Astellas Pharma US INC | $20.92 | 2024 | Veozah |
| Janssen Pharmaceuticals, INC | $20.90 | 2023 | Xarelto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.21 | 2023 | Vaxelis, Rotateq, Vaxneuvance |
| Cranial Technologies, INC | $20.09 | 2023 | Doc Band |
| Abiomed | $19.43 | 2023 | Impella |
| Glaxosmithkline, LLC. | $15.45 | 2022 | |
| Pfizer INC. | $14.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rascon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.